Guidelines : Allergic rhinitis
Detail
Condition :
Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, nasal sprays, allergy, seasonal allergic rhinitis, intranasal antihistamines, intranasal corticosteroids, pollen allergy, INCS, non-sedating antihistamines, ocular antihistamines
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
05 April 2023
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed the Allergic Rhinitis guidance.
A GREEN traffic light status unless stated will be applied to all treatments within the guidance unless otherwise stated.
NON-FORMULARY traffic light status was agreed for the following treatments:
• Desloratadine and levocetirizine oral solutions
• Mizolastine
• Cetirizine capsules
• Rupatadine tablets
• Bilastine tablets
• Acrivastine capsules
BLUE (formerly Amber Star) traffic light status:
• Grazax (Gass Pollen extract) – this recommendation is under review
N/A
Documents
Type
Document
Review Date
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Allergic rhinitis.
- Acrivastine Non Formulary
- Azelastine hydrochloride Green
- Beclometasone Green (see narrative)
- Bilastine Non Formulary
- Budesonide Green (see narrative)
- Cetirizine Green (see narrative)
- Chlorphenamine maleate Green
- Desloratadine Green (see narrative)
- Dust mite allergen extract See narrative
- Fexofenadine Green (see narrative)
- Fluticasone nasal spray Green (see narrative)
- Fluticasone with azelastine (Dymista) Green (see narrative)
- Ipratropium Green
- Ketotifen fumarate Non Formulary
- Levocetirizine Green (see narrative)
- Loratadine Green
- Mizolastine Non Formulary
- Mometasone furoate nasal spray Green
- Mometasone with olopatadine Green (see narrative)
- Promethazine hydrochloride Non Formulary
- Rupatadine Non Formulary
- Triamcinolone acetonide (injection) Non Formulary
- Triamcinolone acetonide (nasal spray) Green (see narrative)